A physiologically based pharmacokinetic - pharmacodynamic modelling approach to predict incidence of neutropenia as a result of drug-drug interactions of paclitaxel in cancer patients
Maïlys De Sousa Mendes, Oliver Hatley, Katherine L. Gill, Karen Rowland Yeo, Alice Ke
Topics & Concepts
Physiologically based pharmacokinetic modellingPharmacologyPharmacokineticsNeutropeniaPaclitaxelMedicinePharmacodynamicsDocetaxelNONMEMConcomitantPopulationDrugCYP3A4CYP2C8KetoconazoleInternal medicineCancerChemotherapyCytochrome P450AntifungalMetabolismEnvironmental healthDermatologyNeutropenia and Cancer InfectionsCancer Treatment and PharmacologyPancreatic and Hepatic Oncology Research